The association between maternal ultra-processed food consumption during pregnancy and child neuropsychological development: A population-based birth cohort study.


Journal

Clinical nutrition (Edinburgh, Scotland)
ISSN: 1532-1983
Titre abrégé: Clin Nutr
Pays: England
ID NLM: 8309603

Informations de publication

Date de publication:
10 2022
Historique:
received: 22 03 2022
revised: 01 08 2022
accepted: 03 08 2022
pubmed: 11 9 2022
medline: 5 10 2022
entrez: 10 9 2022
Statut: ppublish

Résumé

Maternal ultra-processed food (UPF) consumption during pregnancy may adversely affect child development. Pregnancy sugar-sweetened beverage consumption (as a part of UPF) has been associated with child cognitive dysfunction in the general population, but the role of total UPF consumption during pregnancy in later child neuropsychological development has not been studied. We aimed to analyse the association between maternal pregnancy UPF consumption and child neurodevelopment. This study involved 2377 pairs of pregnant women and their offspring from a Spanish birth cohort (recruitment period: 2004-2008, INMA project). Dietary intake was estimated using a 101-item food frequency questionnaire in the third trimester of pregnancy. The NOVA classification was used to identify UPFs, and their consumption was calculated as the daily percentage of total food consumption and categorized into tertiles. Child neuropsychological development was assessed with the Bayley Scales of Infant and Toddler Development (1-year-old, n = 1929) and the McCarthy Scales of Children's Abilities (4-5 years-old, n = 1679). Potential associations were analysed using multivariate linear regression models adjusted for a range of family and child characteristics. UPF consumption among pregnant women represented an average of 17% of the total diet, with sugar-sweetened beverages being the most commonly consumed type of UPF (40%). Children born to mothers in the highest tertile of UPF consumption (28.9% or more of the total diet) vs the lowest tertile (7.2% or less), showed a lower score (B = -2.29 [95% Confidence Interval (CI), -4.13; -0.46]) in the Verbal Scale of the McCarthy Scales (p-for-trend = 0.02). No associations were observed with the McCarthy Scales assessing other cognitive domains or with the Bayley Scales. Of the seven cognitive domains studied, we observed an adverse association between maternal consumption of UPF during pregnancy and verbal functioning in early childhood, which is an important cognitive domain of neurodevelopment.

Sections du résumé

BACKGROUND & AIMS
Maternal ultra-processed food (UPF) consumption during pregnancy may adversely affect child development. Pregnancy sugar-sweetened beverage consumption (as a part of UPF) has been associated with child cognitive dysfunction in the general population, but the role of total UPF consumption during pregnancy in later child neuropsychological development has not been studied. We aimed to analyse the association between maternal pregnancy UPF consumption and child neurodevelopment.
METHODS
This study involved 2377 pairs of pregnant women and their offspring from a Spanish birth cohort (recruitment period: 2004-2008, INMA project). Dietary intake was estimated using a 101-item food frequency questionnaire in the third trimester of pregnancy. The NOVA classification was used to identify UPFs, and their consumption was calculated as the daily percentage of total food consumption and categorized into tertiles. Child neuropsychological development was assessed with the Bayley Scales of Infant and Toddler Development (1-year-old, n = 1929) and the McCarthy Scales of Children's Abilities (4-5 years-old, n = 1679). Potential associations were analysed using multivariate linear regression models adjusted for a range of family and child characteristics.
RESULTS
UPF consumption among pregnant women represented an average of 17% of the total diet, with sugar-sweetened beverages being the most commonly consumed type of UPF (40%). Children born to mothers in the highest tertile of UPF consumption (28.9% or more of the total diet) vs the lowest tertile (7.2% or less), showed a lower score (B = -2.29 [95% Confidence Interval (CI), -4.13; -0.46]) in the Verbal Scale of the McCarthy Scales (p-for-trend = 0.02). No associations were observed with the McCarthy Scales assessing other cognitive domains or with the Bayley Scales.
CONCLUSION
Of the seven cognitive domains studied, we observed an adverse association between maternal consumption of UPF during pregnancy and verbal functioning in early childhood, which is an important cognitive domain of neurodevelopment.

Identifiants

pubmed: 36087519
pii: S0261-5614(22)00291-6
doi: 10.1016/j.clnu.2022.08.005
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2275-2283

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors have indicated they have no potential conflicts of interest to disclose.

Auteurs

Júlia Puig-Vallverdú (J)

Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Barcelona Institute for Global Health (ISGlobal), Barcelona, Catalonia, Spain.

Dora Romaguera (D)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Catalonia, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Madrid, Spain; Instituto de Investigación Sanitaria Illes Balears (IdISBa), Hospital Universitari Son Espases, Palma de Mallorca, Spain. Electronic address: dora.romaguera@isglobal.org.

Sílvia Fernández-Barrés (S)

Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Barcelona Institute for Global Health (ISGlobal), Barcelona, Catalonia, Spain; CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.

Florence Gignac (F)

Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Barcelona Institute for Global Health (ISGlobal), Barcelona, Catalonia, Spain.

Jesús Ibarluzea (J)

Biodonostia Health Research Institute, Paseo Doctor Begiristain s/n, 20013, San Sebastian, Spain; Department of Health of the Basque Government, Subdirectorate of Public Health of Gipuzkoa, Avenida Navarra 4, 20013, San Sebastian, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029, Madrid, Spain; University of the Basque Country (UPV/EHU), Avenida Tolosa 70, 20018, San Sebastian, Spain.

Loreto Santa-Maria (L)

Biodonostia Health Research Institute, Paseo Doctor Begiristain s/n, 20013, San Sebastian, Spain; Department of Health of the Basque Government, Subdirectorate of Public Health of Gipuzkoa, Avenida Navarra 4, 20013, San Sebastian, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029, Madrid, Spain.

Sabrina Llop (S)

CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain; Epidemiology and Environmental Health Joint Research Unit, FISABIO-Universitat Jaume I-Universitat de València, Valencia, Spain.

Sandra Gonzalez (S)

Department of Public Health, History of Medicine and Gynecology, Miguel Hernández University, Spain; Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Spain.

Jesús Vioque (J)

CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain; Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Spain.

Isolina Riaño-Galán (I)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Madrid, Spain; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011, Oviedo, Spain; Servicio de Pediatría. Endocrinología, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain.

Guillermo Fernández-Tardón (G)

CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011, Oviedo, Spain.

Ariadna Pinar (A)

Clinical and Epidemiological Neuroscience (NeuroÈpia), Institut d' Investigació Sanitària Pere Virgili (IISPV), Reus, Catalonia, Spain; Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Barcelona Institute for Global Health (ISGlobal), Barcelona, Catalonia, Spain.

Michelle C Turner (MC)

Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Barcelona Institute for Global Health (ISGlobal), Barcelona, Catalonia, Spain; CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.

Victoria Arija (V)

Nutrition and Mental Health Research Group (NUTRISAM), Universitat Rovira i Virgili URV, Tarragona, Spain; Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.

Jordi Salas-Savadó (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Madrid, Spain; Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain; Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana, Reus, Spain.

Martine Vrijheid (M)

Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Barcelona Institute for Global Health (ISGlobal), Barcelona, Catalonia, Spain; CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.

Jordi Julvez (J)

Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Barcelona Institute for Global Health (ISGlobal), Barcelona, Catalonia, Spain; CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain; Clinical and Epidemiological Neuroscience (NeuroÈpia), Institut d' Investigació Sanitària Pere Virgili (IISPV), Reus, Catalonia, Spain; Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana, Reus, Spain. Electronic address: jordi.julvez@iispv.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH